Navigation Links
Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects
Date:4/4/2011

ndividualize the treatment. Pharmacogenomics, a term that overlaps with pharmacogenetics but is distinct, deals with the application of genomics to drug discovery and development. It involves the mechanism of action of drugs on cells as revealed by gene expression patterns. Pharmacoproteomics is an important contribution to personalized medicine as it is a more functional representation of patient-to-patient variation than that provided by genotyping. A 'pharmacometabonomic' approach to personalizing drug treatment is also described.

Biological therapies such as those which use patient's own cells are considered to be personalized medicines. Vaccines are prepared from individual patient's tumor cells. Individualized therapeutic strategies using monoclonal bodies can be directed at specific genetic and immunologic targets. Ex vivo gene therapy involves the genetic modification of the patient's cells in vitro, prior to reimplantation of these cells in the patient's body.

Various technologies are integrated to develop personalized therapies for specific therapeutic areas described in the report. Examples of this are genotyping for drug resistance in HIV infection, personalized therapy of cancer, antipsychotics for schizophrenia, antidepressant therapy, antihypertensive therapy and personalized approach to neurological disorders. Although genotyping is not yet a part of clinically accepted routine, it is expected to have this status by the year 2014.

Several players are involved in the development of personalized therapy. Pharmaceutical and biotechnology companies have taken a leading role in this venture in keeping with their future role as healthcare enterprises rather than mere developers of technologies and manufacturers of medicines.

Ethical issues are involved in the development of personalized medicine mainly in the area of genetic testing. These along with social issues and consideration of race in the development of personalized medi
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... June 29, 2015  New guidelines released today ... Association give hope for better outcomes to the ... acute ischemic stroke each year. Stryker,s Trevo ® ... used in the clinical trials that provided data ... guidelines strongly recommend endovascular therapy with stent retrievers ...
(Date:6/29/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... public offering of units. Each unit will consist of ... purchase common stock and Series B warrants to purchase ... offering would result in them beneficially owning more than ...
(Date:6/29/2015)... June 29, 2015  Alimera Sciences, Inc. (NASDAQ: ... the research, development and commercialization of prescription ophthalmic pharmaceuticals, ... Officer and Chief Financial Officer, will present at the ... 2015 at 8:00 a.m. ET at Le Parker Meridien ... The presentation will be webcast live and will ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3
... a Standard of Care, WASHINGTON, March 17 ... the Society of Interventional,Radiology,s 33rd Annual Scientific Meeting show ... up a blood clot in most patients,much quicker than ... guided,directly to the clot via a catheter in the ...
... on Outcomes of New Analyses or Confirmatory Trial, ... Tuesday March 18, 2008, BERKELEY HEIGHTS, N.J., ... announced that the Food and Drug,Administration,s (FDA) Center ... available data are not adequate to support approval ...
Cached Medicine Technology:New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 2New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 3New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 4New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 2FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 3FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 4FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 5FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data 6
(Date:6/30/2015)... ... June 30, 2015 , ... Experts estimate that up to ... Back pain can range from a dull, constant ache (chronic) to a sudden sharp ... epidural steroid injections, selective nerve root blocks and rhizotomy treatment, OPTIMAL Pain & ...
(Date:6/30/2015)... ... June 30, 2015 , ... Alice ... a 5-day tour in India. During her stay, she met with the ... Master Wellness™ and Transformational Leader/Internationally Beloved Spiritual Master Mahendra Trivedi to develop ...
(Date:6/30/2015)... ... June 30, 2015 , ... The Glenholme School ... and inspirational words. , The independent, coeducational, special needs boarding school began ... to the school’s Center for the Arts. Along the way, the soon-to-be-graduates paused ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... to enhance successful student outcomes. According to Dr. Theo Wubbels (Professor of ... Teachers must be able to show “all kinds of behavior when the situation ...
(Date:6/30/2015)... ... 30, 2015 , ... Scott Purdy, the spokesperson for Dephinitive Systems LLC, announces ... stated that the XO stands for eXtra Operability (XO) which was chosen to reflect ... the Revenue Cycle. , Provider XO, based in Cleveland OH, is part of ...
Breaking Medicine News(10 mins):Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 3Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 2Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 3Health News:The Glenholme School Graduates Its Class of 2015 2Health News:The Glenholme School Graduates Its Class of 2015 3Health News:The Glenholme School Graduates Its Class of 2015 4Health News:Lessons On Leadership - Top 12 Global Teacher Bloggers Reveal the Best Strategies for Building Positive Leadership in Global Classrooms 2Health News:Dephinitive Systems Is Getting a New Name 2
... Radian Guaranty Inc., the,primary mortgage insurance subsidiary of ... that mortgages originated under "stated income" and "stated,asset" ... insurance. In a,message to clients this week, Radian ... verify assets and income are appropriate,with a disciplined ...
... from UCLA used a high resolution technique to examine the ... embryonic stem cell lines and found that while both lines ... of certain genes that could control such things as individual ... the genome, which contains all the genes on 46 chromosomes, ...
... Ga., March 27 Immucor, Inc.,(Nasdaq: BLUD ), ... blood transfusion industry, today announced that it expects,to release ... after the,close of regular trading hours, and then host ... AM (EDT) to review the results. Investors,are invited to ...
... infections , , THURSDAY, March 27 (HealthDay News) -- ... been determined by biologists at Purdue University in Indiana. ... infects more than 50 million people a year and ... is prevalent in Southeast Asia, Central America and South ...
... Major Studies and Models on, Long-Term Care ... ANNAPOLIS, Md., March 27 The first,comprehensive review ... America,s elderly is now available, the National Investment ... announced today. This major,undertaking, conducted by RTI International ...
... completes fellowship at Stanford University and returns to,Vietnam ... March 27 Three leading California,eye surgeons will ... participate in a,sight-saving mission April 14 - 18 ... state-of-the-art medical and teaching facility housed inside a ...
Cached Medicine News:Health News:Radian Guaranty Inc. Eliminates 'Stated Income' and 'Stated Asset' Programs 2Health News:Radian Guaranty Inc. Eliminates 'Stated Income' and 'Stated Asset' Programs 3Health News:Radian Guaranty Inc. Eliminates 'Stated Income' and 'Stated Asset' Programs 4Health News:UCLA researchers examine human embryonic stem cell genome 2Health News:UCLA researchers examine human embryonic stem cell genome 3Health News:Immucor Schedules Third Quarter Earnings Release and Conference Call 2Health News:Biologists Discover How Dengue Virus Matures 2Health News:Insights on Paying for Boomers' Care Needs in 20-40 Years Helped by New Report 2Health News:Insights on Paying for Boomers' Care Needs in 20-40 Years Helped by New Report 3Health News:Insights on Paying for Boomers' Care Needs in 20-40 Years Helped by New Report 4Health News:Insights on Paying for Boomers' Care Needs in 20-40 Years Helped by New Report 5Health News:California Eye Surgeons Journey to Vietnam to Perform Sight-Saving Surgery 2Health News:California Eye Surgeons Journey to Vietnam to Perform Sight-Saving Surgery 3Health News:California Eye Surgeons Journey to Vietnam to Perform Sight-Saving Surgery 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: